Your browser doesn't support javascript.
The effect of hemoperfusion on the recovery of COVID-19 in hospitalized patients;case series and review study
Immunopathologia Persa ; 7(2):4, 2021.
Article in English | Web of Science | ID: covidwho-1332548
ABSTRACT
Hemoperfusion is an effective modality in removing certain toxins from the blood, especially those that bind to proteins in the body. Hemoperfusion has shown a therapeutic effect on COVID-19 patients. In this case series, we report four patients without effective results following the use of hemoperfusion on the recovery of COVID-19 patients. This study is a case series which carried out on four patients referred to COVID-19 ward of Velayat hospital in Qazvin, Iran. The mean age of the COVID-19 patients was 52.75 +/- 18 years. The mean stay at the hospital was 21.5 +/- 15.15 days. This study showed that hemoperfusion cannot show a significant therapeutic effect on COVID-19.

Full text: Available Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies Language: English Journal: Immunopathologia Persa Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies Language: English Journal: Immunopathologia Persa Year: 2021 Document Type: Article